Proceedings of the Standing Senate Committee on
Social Affairs, Science and Technology

Issue 14 - Minutes of Proceedings - April 25, 2012

OTTAWA, Wednesday, April 25, 2012
(34)

[English]

The Standing Senate Committee on Social Affairs, Science and Technology met this day at 4:14 p.m., in room 2, Victoria Building, the chair, Honourable Kelvin Kenneth Ogilvie, presiding.

Members of the committee present: The Honourable Senators Callbeck, Cordy, Demers, Dyck, Eggleton, P.C., Martin, Merchant, Ogilvie, Seidman, Seth and Verner, P.C. (11).

In attendance: Sonya Norris, Analyst, Parliamentary Information and Research Service, Library of Parliament.

Also in attendance: The official reporters of the Senate.

Pursuant to the order of reference adopted by the Senate on Thursday, November 17, 2011, the committee continued its study on prescription pharmaceuticals in Canada. (For complete text of the order of reference, see proceedings of the committee, Issue No. 12.)

WITNESSES:

BIOTECanada:

Peter Brenders, President and Chief Executive Officer.

Hoffmann-La Roche Ltd.:

Nita Arora, Regional Head Affiliate Management, North America.

Rx&D:

Russell Williams, President;

Ken Hughes, Vice-President, Scientific and Regulatory Affairs.

Amgen Canada Inc.:

Dr. Clive Ward-Able, Executive Director, Research and Development.

The chair made a statement.

Mr. Brenders, Ms. Arora, Mr. Williams and Dr. Ward-Able each made a statement and, together with Mr. Hughes, answered questions.

At 6:12 p.m., the committee adjourned to the call of the chair.

ATTEST:

Jessica Richardson

Clerk of the Committee